Mainstream

Metsera ultra-long acting GLP-1 MET-097i excels in mid-stage trial

Metsera ultra-long acting GLP-1 MET-097i excels in mid-stage trial

Post Contentmtsr, pfeRead More

You might also be interested in reading Zipmex proposes to pay creditors 3 cents per dollar.

September 29, 2025
In Mainstream